{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:29:57Z","timestamp":1779920997970,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001505","name":"The Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["21\/452"],"award-info":[{"award-number":["21\/452"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"The Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["21\/452"],"award-info":[{"award-number":["21\/452"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"The Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["21\/452"],"award-info":[{"award-number":["21\/452"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001505","name":"The Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["21\/452"],"award-info":[{"award-number":["21\/452"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>This study aims to explore the views of Pacific people on how to improve the management of urate-lowering therapy among Pacific gout patients in South Auckland.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study used the Fa\u2019afaletui model to explore the views on gout management across different perspectives of Pacific community members and health professionals working in health providers with high Pacific patient populations. Three workshops were delivered with the community and health professionals. All data were collected by note-takers and analysed using a general inductive approach. Participants were given the opportunity to review the results of the previous workshop before starting the next one.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The key findings from this study clustered into three key themes: [1] Gout interventions guided by Pacific frameworks and research; [2] a multifaceted approach including education, improved access to treatment and screening for gout, and strategies to help Pacific gout patients remain engaged and adherent; and [3] Pacific gout champions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study presents the views of community members of how to improve the uptake of urate-lowering therapy among Pacific gout patients. The community highlighted the need for a multifaceted intervention governed by a Pacific model, addressing access barriers and education for Pacific gout patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12939-025-02465-8","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:38:30Z","timestamp":1743737910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pacific community\u2019s perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-7176","authenticated-orcid":false,"given":"Samuela","family":"Ofanoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-0399","authenticated-orcid":false,"given":"Malakai","family":"Ofanoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8955-1364","authenticated-orcid":false,"given":"Siobhan","family":"Tu\u2019akoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinamaha","family":"Lutui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-2984","authenticated-orcid":false,"given":"Maryann","family":"Heather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-9401","authenticated-orcid":false,"given":"Felicity","family":"Goodyear-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2465_CR1","doi-asserted-by":"crossref","unstructured":"Dalbeth N, Stamp L, Merriman T, Gout. Madison Avenue, New York, NY 10016, United States of America: Oxford University Press; 2016.","DOI":"10.1093\/med\/9780198748311.001.0001"},{"issue":"5","key":"2465_CR2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/art.42393","volume":"75","author":"NA Sumpter","year":"2023","unstructured":"Sumpter NA, Takei R, Cadzow M, Topless RKG, Phipps-Green AJ, Murphy R, et al. Association of gout polygenic risk score with age at disease onset and tophaceous disease in European and Polynesian men with gout. Arthritis Rheumatol. 2023;75(5):816\u201325.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2465_CR3","doi-asserted-by":"crossref","first-page":"e000081","DOI":"10.1136\/bmjmed-2021-000081","volume":"1","author":"K Cai","year":"2022","unstructured":"Cai K, Wu B, Mehta S, Harwood M, Grey C, Dalbeth N, et al. Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in new Zealand. BMJ Med. 2022;1(1):e000081.","journal-title":"BMJ Med"},{"issue":"11","key":"2465_CR4","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/art.41404","volume":"72","author":"S Safiri","year":"2020","unstructured":"Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi\u2010Hashiani A, et al. Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990\u20132017: A systematic analysis of the global burden of disease study 2017. Arthritis Rheumatol. 2020;72(11):1916\u201327.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"2465_CR5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.rdc.2020.07.008","volume":"46","author":"AG Guillen","year":"2020","unstructured":"Guillen AG, Te Karu L, Singh JA, Dalbeth N. Gender and ethnic inequities in gout burden and management. Rheum Dis Clin North Am. 2020;46(4):693\u2013703.","journal-title":"Rheum Dis Clin North Am"},{"key":"2465_CR6","unstructured":"Health Q, Safety. Atlas of Healthcare Variation - Gout: Key Findings 2019 Wellingtion 2019 [updated 06\/07202223\/06\/2023]. Available from: https:\/\/www.hqsc.govt.nz\/our-data\/atlas-of-healthcare-variation\/gout\/"},{"issue":"1485","key":"2465_CR7","first-page":"8","volume":"131","author":"N Dalbeth","year":"2018","unstructured":"Dalbeth N, Dowell T, Gerard C, Gow P, Jackson G, Shuker C, Te Karu L. Gout in Aotearoa new Zealand: the equity crisis continues in plain sight. NZ Med J. 2018;131(1485):8\u201312.","journal-title":"NZ Med J"},{"issue":"Suppl 1","key":"2465_CR8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1907","volume":"8","author":"KG Saag","year":"2006","unstructured":"Saag KG, Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther. 2006;8(Suppl 1):S2.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"2465_CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380\u201390.","journal-title":"Nat Rev Rheumatol"},{"key":"2465_CR10","doi-asserted-by":"crossref","unstructured":"Major TJ, Topless RK, Dalbeth N, Merriman TR. Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. BMJ. 2018;363.","DOI":"10.1136\/bmj.k3951"},{"key":"2465_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-018-0719-3","volume":"20","author":"D Bursill","year":"2018","unstructured":"Bursill D, Dalbeth N. What is the evidence for treat-to-target serum urate in gout? Curr Rheumatol Rep. 2018;20:1\u20139.","journal-title":"Curr Rheumatol Rep"},{"key":"2465_CR12","unstructured":"Arnold J, Harris R, Masina LA, Graham K. Pacific peoples health-Gout data insights. Pharmac; 2022."},{"issue":"1404","key":"2465_CR13","first-page":"37","volume":"127","author":"G Jackson","year":"2014","unstructured":"Jackson G, Dalbeth N, Te Karu L, Winnard D, Gow P, Gerard C, Minko N. Variation in gout care in Aotearoa new Zealand: a National analysis of quality markers. NZ Med J. 2014;127(1404):37\u201347.","journal-title":"NZ Med J"},{"issue":"1543","key":"2465_CR14","first-page":"51","volume":"134","author":"L Te Karu","year":"2021","unstructured":"Te Karu L, Harwood M, Arroll B, Bryant L, Kenealy T. The inequity of access to health: a case study of patients with gout in one general practice. N Z Med J. 2021;134(1543):51\u20138.","journal-title":"N Z Med J"},{"issue":"2","key":"2465_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1071\/HC18082","volume":"11","author":"A Lawrence","year":"2019","unstructured":"Lawrence A, Scott S, Saparelli F, Greville G, Miller A, Taylor A, Gow P. Facilitating equitable prevention and management of gout for Maori in Northland, new Zealand, through a collaborative primary care approach. J Prim Health Care. 2019;11(2):117\u201327.","journal-title":"J Prim Health Care"},{"key":"2465_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12325-014-0175-z","volume":"32","author":"F Perez-Ruiz","year":"2015","unstructured":"Perez-Ruiz F, Dalbeth N, Bardin T. A review of uric acid, crystal deposition disease, and gout. Adv Ther. 2015;32:31\u201341.","journal-title":"Adv Ther"},{"key":"2465_CR17","doi-asserted-by":"crossref","unstructured":"Ofanoa S, Ofanoa M, Tu\u2019akoi S, Lutui H, Heather M, Jansen RM et al. Interventions designed to improve uptake of allopurinol for gout treatment in Aotearoa new Zealand: a scoping review. J Prim Health Care 2022.","DOI":"10.1071\/HC22094"},{"key":"2465_CR18","unstructured":"Andrews S, Gasparini J, Henderson G. Evaluation of Gout Stop and Owning My Gout management programmes: A final report for Arthritis New Zealand and its partners Synergia; 2020."},{"issue":"1","key":"2465_CR19","first-page":"9","volume":"1","author":"RJ Amineh","year":"2015","unstructured":"Amineh RJ, Asl HD. Review of constructivism and social constructivism. J Social Sci Literature Lang. 2015;1(1):9\u201316.","journal-title":"J Social Sci Literature Lang"},{"issue":"4","key":"2465_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/j.1440-1614.2005.01572.x","volume":"39","author":"K Tamasese","year":"2005","unstructured":"Tamasese K, Peteru C, Waldegrave C, Bush A. Ole Taeao Afua, the new morning: A qualitative investigation into Samoan perspectives on mental health and culturally appropriate services. Aust N Z J Psychiatry. 2005;39(4):300\u20139.","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"2465_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/11771801211016854","volume":"17","author":"TT Tuia","year":"2021","unstructured":"Tuia TT, Cobb D. Decolonizing Samoan Fa\u2019afaletui methodology: taking a closer look. AlterNative: Int J Indigenous Peoples. 2021;17(2):275\u201383.","journal-title":"AlterNative: Int J Indigenous Peoples"},{"issue":"2","key":"2465_CR22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1370\/afm.2497","volume":"18","author":"R Lamont","year":"2020","unstructured":"Lamont R, Fishman T, Sanders PF, Goodyear-Smith F. View from the canoe: Co-Designing research Pacific style. Ann Fam Med. 2020;18(2):172\u20135.","journal-title":"Ann Fam Med"},{"issue":"671","key":"2465_CR23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3399\/bjgp18X696425","volume":"68","author":"R Lamont","year":"2018","unstructured":"Lamont R, Fishman T, Goodyear-Smith F. Travelling companions: a story told by a patient and her Doctor. BrJ Gen Pract. 2018;68(671):282.","journal-title":"BrJ Gen Pract"},{"issue":"1","key":"2465_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12939-021-01601-4","volume":"20","author":"M Ofanoa","year":"2021","unstructured":"Ofanoa M, Ofanoa SM, Heather M, Tu\u2019akoi S, Lutui H, Dalbeth N, et al. Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol. Int J Equity Health. 2021;20(1):1\u20137.","journal-title":"Int J Equity Health"},{"issue":"4","key":"2465_CR25","first-page":"334","volume":"5","author":"M Ofanoa","year":"2015","unstructured":"Ofanoa M, Percival T, Huggard P, Buetow S. Talanga: the Tongan way enquiry. Soc Stud. 2015;5(4):334\u201340.","journal-title":"Soc Stud"},{"key":"2465_CR26","doi-asserted-by":"crossref","unstructured":"Gill I, Dalbeth N, Goodyear-Smith F. Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review. BJGP Open. 2020;4(3).","DOI":"10.3399\/bjgpopen20X101051"},{"issue":"2","key":"2465_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"issue":"2","key":"2465_CR28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1098214005283748","volume":"27","author":"DR Thomas","year":"2006","unstructured":"Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237\u201346.","journal-title":"Am J Eval"},{"issue":"6","key":"2465_CR29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3899\/jrheum.210950","volume":"49","author":"Y Emad","year":"2022","unstructured":"Emad Y, Dalbeth N, Weinman J, Chalder T, Petrie KJ. Why do patients with gout not take allopurinol?? J Rheumatol. 2022;49(6):622\u20136.","journal-title":"J Rheumatol"},{"issue":"1","key":"2465_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1071\/HC20112","volume":"13","author":"L Te Karu","year":"2021","unstructured":"Te Karu L, Harwood M, Bryant L, Kenealy T, Arroll B. Compounding inequity: a qualitative study of gout management in an urban Marae clinic in Auckland. J Prim Health Care. 2021;13(1):27\u201335.","journal-title":"J Prim Health Care"},{"issue":"11","key":"2465_CR31","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/1756-185X.14222","volume":"24","author":"W Coleman","year":"2021","unstructured":"Coleman W, Spencer D, Wong P, Manolios N. An enquiry into the crippling gout affecting Pacific Islander and Maori men in Western Sydney. Int J Rheum Dis. 2021;24(11):1394\u2013401.","journal-title":"Int J Rheum Dis"},{"key":"2465_CR32","first-page":"02","volume":"02","author":"R Murdoch","year":"2021","unstructured":"Murdoch R, Jones P, Greenwell J, Dalbeth N. Quality of care in people requiring hospital admission for gout in Aotearoa new Zealand: a nationwide analysis. Intern Med J. 2021;02:02.","journal-title":"Intern Med J"},{"issue":"1429","key":"2465_CR33","first-page":"10","volume":"129","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth N, Gow P, Jackson G, Shuker C, Te Karu L, Gerard C, Winnard D. Gout in Aotearoa new Zealand: are we going to ignore this for another 3 years? NZ Med J. 2016;129(1429):10\u20133.","journal-title":"NZ Med J"},{"issue":"10","key":"2465_CR34","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/rheumatology\/kes147","volume":"51","author":"G Jackson","year":"2012","unstructured":"Jackson G, Wright C, Thornley S, Taylor WJ, Te Karu L, Gow PJ, et al. Potential unmet need for gout diagnosis and treatment: capture-recapture analysis of a National administrative dataset. Rheumatol. 2012;51(10):1820\u20134.","journal-title":"Rheumatol"},{"issue":"2","key":"2465_CR35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10067-012-2110-5","volume":"32","author":"N Dalbeth","year":"2013","unstructured":"Dalbeth N, House ME, Horne A, Te Karu L, Petrie KJ, McQueen FM, Taylor WJ. The experience and impact of gout in M\u0101ori and Pacific people: a prospective observational study. Clin Rheumatol. 2013;32(2):247\u201351.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"2465_CR36","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.24938","volume":"60","author":"JE Hollis-Moffatt","year":"2009","unstructured":"Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in new Zealand M\u0101ori, Pacific Island, and Caucasian case\u2013control sample sets. Arthritis Rheum. 2009;60(11):3485\u201392.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2465_CR37","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/rheumatology\/33.10.932","volume":"33","author":"HA Simmonds","year":"1994","unstructured":"Simmonds HA, McBride MB, Hatfield PJ, Graham R, McCaskey J, Jackson M. Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol. 1994;33(10):932\u20137.","journal-title":"Br J Rheumatol"},{"issue":"24","key":"2465_CR38","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1093\/hmg\/ddq412","volume":"19","author":"AJ Phipps-Green","year":"2010","unstructured":"Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, Merriman ME, Topless R, Gow PJ, et al. A strong role for the ABCG2 gene in susceptibility to gout in new Zealand Pacific Island and Caucasian, but not M\u0101ori, case and control sample sets. Hum Mol Genet. 2010;19(24):4813\u20139.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2465_CR39","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3899\/jrheum.201684","volume":"48","author":"A Ji","year":"2021","unstructured":"Ji A, Shaukat A, Takei R, Bixley M, Cadzow M, Topless RK, et al. Aotearoa new Zealand M\u0101ori and Pacific Population-amplified gout risk variants: CLNK is a separate risk gene at the SLC2A9 locus. J Rheumatol. 2021;48(11):1736\u201344.","journal-title":"J Rheumatol"},{"key":"2465_CR40","doi-asserted-by":"crossref","unstructured":"Te Karu L, Kenealy T, Bryant L, Arroll B, Harwood M. I just wanted to close myself off and die: the long shadow of inequity for M\u00e4ori with gout. MAI J. 2020.","DOI":"10.20507\/MAIJournal.2019.9.2.6"},{"issue":"1","key":"2465_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/acr2.11095","volume":"2","author":"M Kleinst\u00e4uber","year":"2020","unstructured":"Kleinst\u00e4uber M, Wolf L, Jones AS, Dalbeth N, Petrie KJ. Internalized and anticipated stigmatization in patients with gout. ACR Open Rheumatol. 2020;2(1):11\u20137.","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"2465_CR42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3899\/jrheum.150607","volume":"43","author":"S Vaccher","year":"2016","unstructured":"Vaccher S, Kannangara DR, Baysari MT, Reath J, Zwar N, Williams KM, Day RO. Barriers to care in gout: from prescriber to patient. J Rheumatol. 2016;43(1):144\u20139.","journal-title":"J Rheumatol"},{"issue":"2","key":"2465_CR43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1071\/HC15017","volume":"8","author":"C Humphrey","year":"2016","unstructured":"Humphrey C, Hulme R, Dalbeth N, Gow P, Arroll B, Lindsay K. A qualitative study to explore health professionals\u2019 experience of treating gout: Understanding perceived barriers to effective gout management. J Prim Health Care. 2016;8(2):149\u201356.","journal-title":"J Prim Health Care"}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-025-02465-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-025-02465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:39:51Z","timestamp":1743737991000},"score":1,"resource":{"primary":{"URL":"https:\/\/equityhealthj.biomedcentral.com\/articles\/10.1186\/s12939-025-02465-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2465"],"URL":"https:\/\/doi.org\/10.1186\/s12939-025-02465-8","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Auckland Health Research Ethics Committee, Reference no: AH22873.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}